These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15688600)

  • 1. Reversing resistance to targeted therapy.
    Vidal L; Attard G; Kaye S; De Bono J
    J Chemother; 2004 Nov; 16 Suppl 4():7-12. PubMed ID: 15688600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistance to target-based therapy and its circumvention].
    Nishio K
    Nihon Rinsho; 2004 Jul; 62(7):1343-7. PubMed ID: 15283154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanisms of the resistance to molecular targeting agents].
    Akiyama S
    Nihon Rinsho; 2004 Jul; 62(7):1297-304. PubMed ID: 15283147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular targeted therapy].
    Stenner-Liewen F; Zippelius A; Pestalozzi BC; Knuth A
    Chirurg; 2006 Dec; 77(12):1118-25. PubMed ID: 17109101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular target therapy for malignant tumors].
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():76-80. PubMed ID: 15796061
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissecting kinase signaling pathways.
    Boyle SN; Koleske AJ
    Drug Discov Today; 2007 Sep; 12(17-18):717-24. PubMed ID: 17826684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
    Kim R; Toge T
    Surg Today; 2004; 34(4):293-303. PubMed ID: 15052442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of targeted treatments in cancer.
    Abou-Jawde R; Choueiri T; Alemany C; Mekhail T
    Clin Ther; 2003 Aug; 25(8):2121-37. PubMed ID: 14512124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Herceptin and Gleevec.
    Fischer OM; Streit S; Hart S; Ullrich A
    Curr Opin Chem Biol; 2003 Aug; 7(4):490-5. PubMed ID: 12941424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeted drugs in radiation therapy].
    Favaudon V; Hennequin C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S114-20. PubMed ID: 15679256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib mesylate.
    Waller CF
    Recent Results Cancer Res; 2010; 184():3-20. PubMed ID: 20072827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The new mechanisms and reversal of drug resistance].
    Akiyama S
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):1-8. PubMed ID: 12557697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems in the current target therapy of malignancies].
    Stukov AN; Gershanovich ML; Filov VA; Imianitov EN
    Vopr Onkol; 2005; 51(5):607-11. PubMed ID: 16756022
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiac toxicity and edema].
    Takeuchi S; Sakai H
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1654-8. PubMed ID: 18931565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological aspects of current problems in target-based anticancer drug development.
    Yamanaka T; Okamoto T; Ichinose Y; Oda S; Maehara Y
    Int J Clin Oncol; 2006 Jun; 11(3):167-75. PubMed ID: 16850122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 as a target for breast cancer therapy.
    Tagliabue E; Balsari A; Campiglio M; Pupa SM
    Expert Opin Biol Ther; 2010 May; 10(5):711-24. PubMed ID: 20214497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.
    Becker JC; Muller-Tidow C; Serve H; Domschke W; Pohle T
    World J Gastroenterol; 2006 Jun; 12(21):3297-305. PubMed ID: 16733844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal first-line treatment of chronic myeloid leukemia. How to use imatinib and what role for newer drugs?
    Jabbour E; Cortes J; Kantarjian H
    Oncology (Williston Park); 2007 May; 21(6):653-62; discussion 663-4, 667-8. PubMed ID: 17564324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.
    Rochat B
    Clin Pharmacokinet; 2005; 44(4):349-66. PubMed ID: 15828850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer: not just for smokers. People who never smoked may have a different form of the disease that responds better to a new generation of targeted medications.
    Harv Health Lett; 2007 Jan; 32(3):4-5. PubMed ID: 17323498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.